Emerging drugs for chronic urticaria

Expert Opinion on Emerging Drugs
Riccardo Asero, Alberto Tedeschi

Abstract

Chronic urticaria (CU), with or without angioedema, is a frequent disorder defined as the occurrence of pruritic wheals for > 6 weeks. Studies carried out in the last two decades showed that the origin of the disease is autoimmune in up to 50% of cases. Currently available treatments include antihistamines, corticosteroids and ciclosporin; recently, leukotriene receptor antagonists proved effective in a subset of patients as well. For patients with an unremitting and extremely severe disease unresponsive to standard treatments, plasmapheresis and immunosuppressive drugs have been successfully attempted. Recent findings that the autologous plasma skin test scores positive in nearly all patients and that plasmas from patients with both autoimmune and 'idiopathic' chronic urticaria are frequently characterised by signs of thrombin activation (plasma levels of prothrombin fragment F(1.2) are significantly increased) suggest that clotting cascade might be somehow involved in the pathogenesis of CU. These findings put under a new light some rather sparse studies of the effect of drugs active on the coagulation system (heparin and oral anticoagulants) in patients with CU.

References

Jan 1, 1977·Archives of Dermatology·E W Monroe, H E Jones
Dec 1, 1978·The British Journal of Dermatology·C A Commens, M W Greaves
Jan 1, 1975·Acta Anatomica·D Ruano-Gil, A Tejedo-Mateu
May 2, 1992·Lancet·C E GrattanM W Greaves
Apr 1, 1992·The British Journal of Dermatology·R J Barlow, M W Greaves
Dec 1, 1991·The Journal of Allergy and Clinical Immunology·A M Jaffer
Nov 1, 1991·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·C E GrattanM W Greaves
Dec 1, 1991·Journal of the American Academy of Dermatology·M S FradinJ J Voorhees
Jun 1, 1991·International Journal of Dermatology·R G SibbaldS Tarlo
Dec 1, 1990·The Journal of Allergy and Clinical Immunology·J KalivasM Bigby
Feb 1, 1988·The Journal of Investigative Dermatology·B L GruberA P Kaplan
Nov 26, 1988·BMJ : British Medical Journal·J Berth-JonesV E Mitchell
Aug 1, 1988·The Journal of Allergy and Clinical Immunology·E P Brestel, L B Thrush
May 1, 1986·The British Journal of Dermatology·C E GrattanJ W Bradfield
Nov 1, 1986·The Journal of Allergy and Clinical Immunology·A B GoldsobelR J Barr
Mar 1, 1986·Southern Medical Journal·L A DuvallR G King
Mar 1, 1985·The Journal of Allergy and Clinical Immunology·C D May
Apr 1, 1974·The British Journal of Dermatology·N BerovaV C Andreev
Aug 1, 1969·The British Journal of Dermatology·R H ChampionJ H Roger
Oct 1, 1981·The Journal of Allergy and Clinical Immunology·R P HarveyA L Schocket
May 1, 1984·The Journal of Allergy and Clinical Immunology·L R LopezA L Schocket
Jul 1, 1993·The Journal of Allergy and Clinical Immunology·J ClaveauJ Hébert
Jun 29, 1995·The New England Journal of Medicine·M W Greaves
Jan 1, 1993·The American Review of Respiratory Disease·S D BowlerP S Lavercombe
Dec 1, 1995·The Journal of Allergy and Clinical Immunology·J S RumbyrtA L Schocket
Oct 1, 1996·The Annals of Pharmacotherapy·D L Breneman
Feb 1, 1997·The British Journal of Dermatology·B F O'DonnellM W Greaves
Mar 1, 1997·Clinical Therapeutics·E W Monroe
Feb 4, 1998·The Journal of Allergy and Clinical Immunology·D G EboL Matthieu
Mar 28, 1998·Experimental Dermatology·M W Greaves, B F O'Donnell
Apr 16, 1998·The British Journal of Dermatology·B F O'DonnellM W Greaves
May 9, 1998·The Journal of Allergy and Clinical Immunology·S Spector, R A Tan
Nov 18, 1998·The Journal of Allergy and Clinical Immunology·M H Ellis
Feb 20, 1999·Journal of the American Academy of Dermatology·W R Heymann
Apr 21, 1999·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·J RingR Engst
Jun 9, 1999·The Journal of Allergy and Clinical Immunology·U FagioloA Amadori
Jul 10, 1999·The Journal of Allergy and Clinical Immunology·M FerrerA P Kaplan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.